Zacks Investment Research on MSN

PacBio stock up on HiFi sequencing adoption for major SUDC research

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced that its HiFi whole-genome ...
TMCnet

PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)

Applying HiFi sequencing as a first-tier assay is designed to consolidate and simplify the laboratory workflow especially in ...
Morningstar

PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications

MENLO PARK, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a significant advancement for ...
Business Insider

PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes

MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the ...
Seeking Alpha

PacBio Celebrates Nature Methods Naming Long-Read Sequencing "Method of the Year"

MENLO PARK, Calif., Jan. 13, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today celebrated long-read sequencing being named ...
Seeking Alpha

PacBio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis

MENLO PARK, Calif., Oct. 11, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the availability of PacBio WGS ...
Nasdaq

PacBio Joins 1000 Genomes Long Read Sequencing Project to Enhance Human Genomics Research

PacBio has announced its participation in the 1000 Genomes Long Read Sequencing Project, contributing long-read transcriptome data to enhance this significant human genomics initiative. Through ...
GEN - Genetic Engineering and Biotechnology News

The Throughput Paradox: Why Next-Generation Sequencing Bottlenecks Persist Beyond the Sequencer

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced preliminary unaudited revenue for the ...
FierceBiotech

PacBio to cut headcount, costs in face of tariff headwinds

Pacific Biosciences is reducing both headcount and spending across its DNA sequencing business, in the face of escalating global tariffs and threats to federal biomedical research grants. Looking to ...